Examining Go-or-Grow Using Fluorescent Cell-Cycle Indicators and Cell-Cycle-Inhibiting Drugs
- PMID: 32087771
- PMCID: PMC7091499
- DOI: 10.1016/j.bpj.2020.01.036
Examining Go-or-Grow Using Fluorescent Cell-Cycle Indicators and Cell-Cycle-Inhibiting Drugs
Abstract
The go-or-grow hypothesis states that adherent cells undergo reversible phenotype switching between migratory and proliferative states, with cells in the migratory state being more motile than cells in the proliferative state. Here, we examine go-or-grow in two-dimensional in vitro assays using melanoma cells with fluorescent cell-cycle indicators and cell-cycle-inhibiting drugs. We analyze the experimental data using single-cell tracking to calculate mean diffusivities and compare motility between cells in different cell-cycle phases and in cell-cycle arrest. Unequivocally, our analysis does not support the go-or-grow hypothesis. We present clear evidence that cell motility is independent of the cell-cycle phase and that nonproliferative arrested cells have the same motility as cycling cells.
Copyright © 2020 Biophysical Society. Published by Elsevier Inc. All rights reserved.
Figures
References
-
- Hoek K.S., Eichhoff O.M., Dummer R. In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res. 2008;68:650–656. - PubMed
-
- Zipser M.C., Eichhoff O.M., Hoek K.S. A proliferative melanoma cell phenotype is responsive to RAF/MEK inhibition independent of BRAF mutation status. Pigment Cell Melanoma Res. 2011;24:326–333. - PubMed
-
- Giese A., Bjerkvig R., Westphal M. Cost of migration: invasion of malignant gliomas and implications for treatment. J. Clin. Oncol. 2003;21:1624–1636. - PubMed
-
- Czirók A., Schlett K., Vicsek T. Exponential distribution of locomotion activity in cell cultures. Phys. Rev. Lett. 1998;81:3038–3041.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
